Another symmetric triangle strategy. The stock could possible start a fresh bull rally to breakout of its long term trend channel. The stop loss at 420. Target around 560.
Price making higher highs and higher lows. After each high there is sell off and movement towards the trend line followed by a breakout. CMP SL:85.15 Target:95
Expecting the stock to move towards its pre-covid highs, but due to uncertainty, the first target can be at 177. SL at 135.5, giving RR of 3:1 at CMP. The stop loss can be trailing and cut half the position at target, to reduce risk on profit earned.
Showing signs of weakness and having broken through the short term support at around 387, I am expecting the price to correct down to levels of 315 in the short term, before returning upwards. The banking sector has shown overall weakness and IndusInd bank has shown been worse.
The price is at the higher end of the short term range (1007), expecting a reversal down to the lower end of the range(968).
The stock has attempted a breakout from 185 zones 3 times and has reached a stable point, with the good performance of the metal sector, JSW is a long opportunity with a good breakout towards 203.
The set up looks good, with Fib retracement, showing a good RR. SL at 185 and Target at 215
The price is a the important 0.5 retracement level. The short term Target is 107.05 with SL at 96.5. Providing a RR of 1:2.5
The trend appears to be bullish because the price is making higher highs and higher lows. Buy at CMP, Sl at 118.15 and Target at 153.95.
There is a congestion zone around 349, where the price has found support and moved upwards. Offering a 2.5:1 RR, which can be increased with a trailing stop loss. Buy at 366, Sl at 352 and Target at 405-406.
The stock has recovered sharply and has found support at the pre-virus high point. It has also been in consolidation for the past few days, and may continue on it's upward trend this week. Keep an eye on the stock. The support level is at 610-615 zone. Expecting a breakout above 650 this week. Pharma sector has been a strong performer in this crash and will...
The price has found support 2 times at the same marked level of 467. I am expecting the stock to move towards the upper end (510) of the fairly wide range it has created recently.
Bank Nifty overall has been getting hammered over the past couple of weeks and I am expecting some further weakness with the increase in the moratorium period by 3 months. The next support for AXIS BANK is 324.
With the strong recovery of the pharma sector, Glenmark is at the pre-virus levels and has been attempting to breakout of the range. The sector has been in consolidation for several days and it may attempt a breakout to slightly higher levels. The pharma sector may not face sell offs in the midst of the pandemic, in my opinion.
The RSI reading indicates that the stock is at a near term resistance and could see some downside. There have been strong significant green bars and may see some correction or possibly a reversal. A correction and profit taking can be observed around levels of 199, if it breaks down further then that could indicate reversal around 178 levels.
The stock has been on a steady decline. I am expecting it to decline towards 500 and find support. This presents a good shorting opportunity with the marked support as the target price. With a StopLoss at 565.
This is presenting a good shorting opportunity at the current levels as the stock may retrace to the lower levels of 330. If that low is broken then the next target would be 305. Just Dial did have a good earnings report though but has faced a sell of intra-day nonetheless.